Elide Matano

2.0k citations
49 papers · 1.7k · 1 hit paper · h-index 15

Impact in

Papers in

    • Cancer Treatment and Pharmacology 5
    • Colorectal Cancer Treatments and Studies 3
    • Cancer Immunotherapy and Biomarkers 3
    • Gastric Cancer Management and Outcomes 3
    • Lung Cancer Treatments and Mutations 3

Elide Matano

49 papers receiving 1.6k citations

Elide Matano's Hit Papers

Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer 2002 · 778 citations
7780+8+16Years since publication250500750

Peers

Elide Matano
Comparison fields: 5 of 83
  • Internal Medicine 125
  • Pulmonary and Respiratory Medicine 726
  • Oncology 594
  • Cancer Research 119
  • Neurology 76
Replace Thomas John Semrad with:
Thomas John Semrad United States
Stefano Cereda Italy
Gilles Quéré France
Kaitlin M. Woo United States
Takahide Kodama Japan
Oscar Reig Torras Spain
Laëtitia Mauge France
Francis Daniel United Kingdom
Sanjaykumar Hapani United States
Isaac Alex Bowman United States
Elide Matano relative to Thomas John Semrad United States Thomas John Semrad's profile →
Citations per field
00.5×2×3×3.6×
Thomas John Semrad · 1×
Citations per year

Countries citing papers authored by Elide Matano

Since Specialization
Citations

This map shows the geographic impact of Elide Matano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elide Matano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elide Matano more than expected).

Fields of papers citing papers by Elide Matano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elide Matano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elide Matano. The network helps show where Elide Matano may publish in the future.

Co-authors

The 25 scholars most cited alongside Elide Matano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elide Matano Line = papers co-authored together Elide Matano links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer
Hit paper breakdown →
2002778
2 2005160
3 2017135
4 199188
5 201169
6 200046
7 201143
8 202141
9 201940
10 201223
11 199821
12 202219
13 201218
14 201318
15 199316
16
Low-dose recombinant IL-2 induces psychological changes: monitoring by Minnesota Multiphasic Personality Inventory (MMPI).
200214
17 200214
18 202111
19 202211
20 201210

About Elide Matano

Elide Matano is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Neurology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 49 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Myasthenia Gravis and Thymoma (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Adrenal and Paraganglionic Tumors (3 papers), Gastric Cancer Management and Outcomes (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Pituitary Gland Disorders and Treatments (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Internal Medicine (125 citations), Pulmonary and Respiratory Medicine (726 citations), Oncology (594 citations), Cancer Research (119 citations) and Neurology (76 citations). Elide Matano has collaborated with scholars based in Italy, France and United States. Frequent co-authors include Sabino De Placido, Corrado Boni, Francesco Di Costanzo, Maurizio Marangolo, Luca Frontini, Filippo de Marinis, Giuseppe Failla, Cesare Gridelli, Maurizia Clerici and Monica Rinaldi. Their work appears in journals such as Anti-Cancer Drugs, British Journal of Cancer, Annals of Oncology, European Journal of Cancer and International Journal of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact